StockData
Lakefront Biotherapeutics NV logo

Lakefront Biotherapeutics NV (LKFT) stock

LKFTNasdaqPharmaceutical PreparationsAlso trades as GLPGF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Score 7/30
$34.39−0.40 (-1.15%)

Close on Nov 17, 2026Market cap $2.27BP/E 6.4Yield –

Lakefront Biotherapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Lakefront Biotherapeutics's enterprise value was $2.10B on Nov 11, 2026, against $1.99B a year earlier. Over the last 5 years it ranged from $299.43M to $2.22B, with a median of $1.77B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.10B+0.9%
2025Dec 31, 2025$2.08B+26.9%
2024Dec 31, 2024$1.64B-22.3%
2023Dec 29, 2023$2.11B+307.4%
2022Dec 30, 2022$517.63M-13.2%
2021Dec 31, 2021$596.65M-78.6%
2020Dec 31, 2020$2.79B-70.6%
2019Dec 31, 2019$9.49B+186.1%
2018Dec 31, 2018$3.32B+1.6%
2017Dec 29, 2017$3.27B+69.0%
2016Dec 30, 2016$1.93B–

More Lakefront Biotherapeutics figures

See a number that looks wrong?